Everand Logo

Welcome to Everand!

  • STAT

    7 things to know about the pharma CEO who incurred Trump’s wrath

    President Trump on Twitter took personal aim at Kenneth Frazier, CEO of Merck, after Frazier stepped down from the president's advisory council.
    by Rebecca Robbins Aug 14, 2017 4 minutes
    Kenneth Frazier, CEO of Merck, speaks at a White House event in July 2017.

    Kenneth Frazier on Monday morning went from being a mostly anonymous pharma CEO to taking center stage in the political conversation — thanks to an angry tweet from President Trump.

    Frazier, the CEO of drug giant Merck, announced that he was advising Trump, citing “a responsibility to take a stand against violence and extremism” after Trump’s failure to denounce the actions of white nationalists in Charlottesville, Va., over the weekend. Within an hour, Trump personally rebuked him , saying Frazier’s departure would give him “more time to LOWER RIPOFF DRUG PRICES!” And at the end of the day, in another tweet, Trump added another accusation: “taking jobs out of the

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
    Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

    Related Books & Audiobooks